Respiratory syncytial virus and other respiratory viruses

Pediatric Infectious Disease Journal

Volumn 22, Issue SUPPL. 2, 2003, Pages

  Welliver, Robert C ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Epidemiology; Immunology; Influenza; Metapneumoviruses; Parainfluenza; Respiratory syncytial virus

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN;

ASTHMA; BRONCHIOLITIS; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; EOSINOPHILIA; FAMILY HISTORY; HELPER CELL; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOLOGY; INFLAMMATORY CELL; INFLUENZA VIRUS; LYMPHOCYTE PROLIFERATION; METAPNEUMOVIRUS; OXYGEN SATURATION; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS VIRULENCE;

ANTIBODY FORMATION; ASTHMA; CHILD; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; INCIDENCE; INFLAMMATION; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK FACTORS; T-LYMPHOCYTES;

EID: 0037323546     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200302001-00002     Document Type: Conference Paper

References (48)

1. Shay DK, Holman RC, Roosevelt GE, et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis 2001;183:16-22.
2. Shay DK, Holman RC, Newman D, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-6.
3. Anderson LJ, Heilman CA. Protective and disease-enhancing immune responses to respiratory syncytial virus. J Infect Dis 1995;171:1-7.
4. Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 1998:2084-111.
5. Sigurs N, Bjarnason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000;161:1501-7.
6. Openshaw PJM. Potential therapeutic implications of new insights into respiratory syncytial virus disease. Respir Res 2002;3(Suppl 1):S15-20.
7. Glezen WP, Couch RB. Influenza viruses. In: Evans AS, ed. Viral infections of humans: epidemiology and control. 3rd ed. New York: Plenum, 1991:424.
8. Sullender WM, Mufson MA, Prince GA, et al. Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children. J Infect Dis 1998;178:925-32.
9. Mufson MA, Belshe RB, Orvell C, et al. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol 1987;25:1535-9.
10. Hall CB, Walsh EE, Schnabel KC, et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 1990;162:1283-90.
11. McConnochie KM, Hall CB, Walsh EE, et al. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr 1990;117:52-62.
12. Simoes E, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J 2003;22(Suppl): S00-00.
13. Holberg CJ, Wright AL, Martinez FD, et al. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first years of life. Am J Epidemiol 1991;133: 1135-51.
14. Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: A developed country perspective. Respir Med 2002;96(Suppl B):S1-7.
15. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr 1992;121: 348-54.
16. Glezen WP, Paredes A, Allison JE, et al. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981;98:708-15.
17. Toms GL, Scott R. Respiratory syncytial virus and the infant immune response. Arch Dis Child 1987;62:544-6.
18. Kaul TN, Welliver RC, Wong DT, et al. Secretory antibody response to respiratory syncytial virus infection. Am J Dis Child 1981;135:113-6.
19. McIntosh K, Masters HB, Orr I, et al. The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis 1978;138:24-32.
20. Garofalo RP, Welliver RC, Ogra PL. Clinical aspects of bronchial reactivity and cell-virus interaction. In: Ogra PL, Mestecky J, Lamm E, et al., eds. Mucosal immunology. 2nd ed. San Diego: Academic Press, 1999:1223-38.
21. Fishaut M, Tubergett D, McIntosh K. Prolonged respiratory viral infections in children with disorders of cell mediated immunity. J Pediatr 1980;96:179-86.
22. Kim HW, Leikin SL, Arrobio J, et al. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr Res 1976;10:75-8.
23. van Schaik SM, Tristram DA, Nagpal IS, et al. Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing. J Allergy Clin Immunol 1999;103: 630-6.
24. Garofalo RP. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 2001; 184:393-9.
25. Romagnani S. Induction of Th1 and Th2 responses: a key role for the "natural" immune response? Immunol Today 1992;13: 372-81.
26. Folkerts G, Buse WW, Nijkamp FP, et al. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998;157:1708-20.
27. Openshaw PJM, Pala P, Sparer T, et al. T-cell subsets and lung inflammation: lessons from respiratory syncytial virus. Eur Respir Rev 2000;10:108-11.
28. Hall CB, Hall WJ, Gala CL, et al. Long-term prospective study in children after respiratory syncytial virus infection. J Pediatr 1984;105:358-64.
29. Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics 2002;109(2 Suppl): 362-7.
30. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-5.
31. McConnochie KM, Roghmann KJ. Wheezing at 8 and 13 years: changing importance of bronchiolitis and passive smoking. Pediatr Pulmonol 1989;6:138-46.
32. Ehlenfield DR, Cameron K, Welliver RC. Eosinophilia at the time of respiratory syncytial virus bronchiolitis predicts childhood reactive airway disease. Pediatrics 2000;105:79-83.
33. Zhao J, Takamura M, Yamaoka A, et al. Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood. Pediatr Allergy Immunol 2002;13:47-50.
34. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
35. Del Prete G, Maggi E, Parronchi P, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140:193-8.
36. Welliver RC, Wong DT, Sun M, et al. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 1981;305:841-6.
37. Garofalo RP, Kimpen JLL, Welliver RC, et al. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992; 120:28-32.
38. Rot A, Krieger M, Brunner T, et al. RANTES and macrophage inflammatory protein-1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176:1489-95.
39. Alam R, Forsythe PA, Stafford S, et al. Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J Exp Med 1992;176:781-6.
40. Kimata H, Yoshida A, Ishioka C, et al. RANTES and macrophage inflammatory protein-1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J Exp Med 1996;183:2397-402.
41. Haeberle HA, Kuziel WA, Dieterich HG, et al. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1 alpha in lung pathology. J Virol 2001;75:878-90.
42. Welliver RC, Wong DT, Sun M, et al. Parainfluenza virus bronchiolitis: epidemiology and pathogenesis. Am J Dis Child 1986;140:34-40.
43. Van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001;7:719-24.
44. Nissen MD, Siebert DJ, Mackay IM, et al. Evidence of human metapneumovirus in Australian children. Med J Aust 2002; 18:176-88.
45. Peret TC, Boivin G, Li Y, et al. Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis 2002;185:1660-3.
46. Sprenger H, Meyer RG, Kaufmann A, et al. Selective induction of monocyte and not neutrophil-attracting chemokines after influenza A virus infection. J Exp Med 1996;184: 1191-6.
47. Garofalo RP, Hintz KE, Hill V, et al. The role of the chemokines RANTES, MIP-1α, and MCP-1 in influenza virus infection [Abstract] Presented at the American Acadmy of Allergy, Asthma, and Immunology Annual Meeting, New Orleans, March 16 to 21, 2001.
48. Kaiser L, Fritz RS, Straus SE, et al. Symptom pathogenesis during acute influenza: interleukin 6 and other cytokine responses. J Med Virol 2001;64:262-8.